Transcatheter aortic valve replacement (TAVR) is an established treatment for severe,
symptomatic, aortic stenosis (AS) in patients of all risk categories and now comprises 12.5 …

Background: Transcatheter aortic valve replacement (TAVR) is now the standard of care for
patients with symptomatic severe aortic stenosis who are extreme, high, or intermediate risk …

Objectives: This study sought to evaluate whether frailty improves mortality prediction in
combination with the conventional scores. Background: European System for Cardiac …

Background Transcatheter Aortic Valve Implantation (TAVI) procedures are rapidly
expanding, necessitating a more extensive stratification of patients with aortic stenosis …

Background: Transcatheter aortic valve replacement (TAVR) is increasingly being used for
treatment of severe aortic valve stenosis in patients at intermediate risk for surgical aortic …

Background Surgical risk prediction models are routinely used to guide decision-making for
transcatheter aortic valve replacement (TAVR). New and updated TAVR-specific models …

Abstract OBJECTIVES The European System for Cardiac Operative Risk Evaluation II
(EuroSCORE II) and the Society of Thoracic Surgeons (STS) score are currently used to …

Background Glycemic variability is associated with worse outcomes after cardiac surgery,
but the prognosis value of early glycemic variability after transcatheter aortic valve …

Objective Transcatheter mitral valve-in-valve/valve-in-ring procedures (TM-VIVoR) are
increasing. The authors aimed to identify independent predictors for hospital mortality in …

Transcatheter aortic root repair (TARR) is still not available because of the complex
anatomy. In order to develop future TARR technologies, a human-derived bench test model …